Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphoma, Non-Hodgkin × Selenium × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 4 Male Urogenital Diseases 2 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1

Interventions

Cyclophosphamide 129 Rituximab 122 Etoposide 73 fludarabine phosphate 56 Peripheral Blood Stem Cell Transplantation 55 Busulfan 53 Mycophenolic Acid 52 Filgrastim 52 Melphalan 51 Tacrolimus 42 Whole-Body Irradiation 40 fludarabine 39 Radiotherapy 39 Cytarabine 39 Methotrexate 33 Cyclosporine 33 Granulocyte Colony-Stimulating Factor 32 Antilymphocyte Serum 30 Vincristine 29 Carmustine 29 Doxorubicin 23 thymoglobulin 21 Prednisone 21 Bendamustine Hydrochloride 21 Thiotepa 20 Methylprednisolone 20 Ifosfamide 18 Dexamethasone 17 plerixafor 16 sargramostim 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00455416 2008-05-21

KLYMF

Oslo University Hospital

Phase 2 Unknown

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡